{
  "id": "fd7cd7995ca7801a",
  "title": "Farmaci per tumori , malattie cardiovascolari , oncoematologiche : qual \u00e8 limpatto nella vita reale ? ",
  "description": "20260212T163000Z",
  "content": "",
  "source": "corriere.it",
  "source_url": "https://www.corriere.it/salute/cardiologia/26_febbraio_12/farmaci-per-tumori-malattie-cardiovascolari-oncoematologiche-qual-e-l-impatto-nella-vita-reale-1fd3f091-2ff1-4f9b-8ba8-5681a101axlk.shtml",
  "published_at": "20260212T163000Z",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Italy",
  "raw_data": {
    "url": "https://www.corriere.it/salute/cardiologia/26_febbraio_12/farmaci-per-tumori-malattie-cardiovascolari-oncoematologiche-qual-e-l-impatto-nella-vita-reale-1fd3f091-2ff1-4f9b-8ba8-5681a101axlk.shtml",
    "url_mobile": "https://www.corriere.it/salute/cardiologia/26_febbraio_12/farmaci-per-tumori-malattie-cardiovascolari-oncoematologiche-qual-e-l-impatto-nella-vita-reale-1fd3f091-2ff1-4f9b-8ba8-5681a101axlk_amp.shtml",
    "title": "Farmaci per tumori , malattie cardiovascolari , oncoematologiche : qual \u00e8 limpatto nella vita reale ? ",
    "seendate": "20260212T163000Z",
    "socialimage": "https://dimages2.corriereobjects.it/files/og_thumbnail/uploads/2026/02/12/698db5c557871.jpeg",
    "domain": "corriere.it",
    "language": "Italian",
    "sourcecountry": "Italy"
  }
}